Market closed

TransMedics Group/$TMDX

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About TransMedics Group

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Ticker

$TMDX
Sector
Health Care
Trading on
NASDAQ

Industry

Health Care Equipment & Supplies
Headquarters
Andover, United States

Employees

584
Website
www.transmedics.com

TMDX Metrics

BasicAdvanced
$2.1B
68.35
$0.94
1.99
-

$2.1B

1.99

$177.37

$58.27

2.3M

8.201

6.998

245.619

246.83

2.32%

2.84%

19.41%

68.348

5.269

10.24

10.96

-17.535

109.09%

-184.77%

142.23%

-12.07%

What the Analysts think about TMDX

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for TransMedics Group stock.

TMDX Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

TMDX Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-

TMDX News

AllArticlesVideos
TransMedics Group, Inc. Is Being Investigated For Securities Law Violations And Impacted Shareholders Are Urged To Contact The Schall Law Firm

TransMedics Group, Inc. Is Being Investigated For Securities Law Violations And Impacted Shareholders Are Urged To Contact The Schall Law Firm

Accesswire·4 hours ago
TransMedics Group, Inc. Investors: Company Investigated by the Portnoy Law Firm

TransMedics Group, Inc. Investors: Company Investigated by the Portnoy Law Firm

GlobeNewsWire·6 hours ago
TMDX Investors Have Opportunity to Join TransMedics Group, Inc. Securities Fraud Investigation with the Schall Law Firm

TMDX Investors Have Opportunity to Join TransMedics Group, Inc. Securities Fraud Investigation with the Schall Law Firm

Business Wire·10 hours ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $TMDX

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for TransMedics Group stock?

TransMedics Group (TMDX) has a market cap of $2.1B as of January 15, 2025.

What is the P/E ratio for TransMedics Group stock?

The price to earnings (P/E) ratio for TransMedics Group (TMDX) stock is 68.35 as of January 15, 2025.

Does TransMedics Group stock pay dividends?

No, TransMedics Group (TMDX) stock does not pay dividends to its shareholders as of January 15, 2025.

When is the next TransMedics Group dividend payment date?

TransMedics Group (TMDX) stock does not pay dividends to its shareholders.

What is the beta indicator for TransMedics Group?

TransMedics Group (TMDX) has a beta rating of 1.99. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.